RecruitingNot ApplicableNCT06475391
The Effects of L-arginine Supplementation on Anaerobic Exercise Performance
Sponsor
University of Manitoba
Enrollment
20 participants
Start Date
Jun 14, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate if acute ingestion of L-arginine will enhance anaerobic exercise performance in young, healthy, and recreationally active adults.
Eligibility
Min Age: 18 YearsMax Age: 39 Years
Inclusion Criteria1
- Recreationally physically active individuals will be recruited for the study. In this context it means all participants perform 1-hour of exercise per day over 3-days per week at a minimum for 1-month. All participants will be between the ages of 18-39 years of age.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTL-arginine
2 grams iof L-arginine will be ingested before an acute testing bout of exercise tasks in 250 mL of cranberry juice.
DIETARY_SUPPLEMENTPlacebo
Placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06475391
Related Trials
Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of Overreaching in Healthy Men
NCT074815781 location
Molecular Indicators of Systematic Fitness
NCT073938411 location
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
NCT070915001 location
Targeting Oxidative Stress to Prevent Vascular and Skeletal Muscle Dysfunction During Disuse
NCT043511131 location
Skeletal Muscle Myokine Response to Acute Eccentric Exercise
NCT066777491 location